A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction

Lignende værker

• Expansion of Effector Memory Regulatory T-cells Represents A Novel Prognostic Factor in Lower Risk Myelodysplastic Syndrome
  af: Mailloux, Adam W, et al.
  Udgivet: (2012)
• Immune dysregulation in myelodysplastic syndrome
  af: Sugimori, Chiharu, et al.
  Udgivet: (2010)
• ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia
  af: Padron, Eric, et al.
  Udgivet: (2014)
• Reversal of T-cell Tolerance in Myelodysplastic Syndrome through Lenalidomide Immune Modulation
  af: McDaniel, Jessica M., et al.
  Udgivet: (2011)
• Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromes
  af: Mailloux, Adam W., et al.
  Udgivet: (2013)